Antihypertensive Drugs Market Analysis: By Type (Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, ARBs, Calcium Channel Blockers, Beta Blockers, Alpha Blockers, Vasodilators & Renin Inhibitors); – With Forecast (2016-2021)
[Report Updated: 27-01-2016]


Related Topics: Hypertension

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Antihypertensive
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

Hypertension is a medical condition in which the blood pressure of an individual is elevated to a level beyond what is the desired level. As a result of this, a number of other conditions such as blood pressure and mental distress can take place. The number of cases of hypertension has grown exponentially in the last decade. Key reason for this has been the drastic change in lifestyle and diet intake. Within individuals working around the clock around different time zones, the required time for an individual to take rest is no longer sufficient. Individuals need plenty of sleep to recover and to be reenergized, however, exactly the opposite takes place with people not getting enough sleep, no exercise, no proper intake of healthy food all of which adds to hypertension in the long run.

Once the condition of hypertension has set in, the drugs which are required to keep this under control may be required for the rest of the individual’s life depending on the severity of the condition. In a way, this in itself is a case for the drug developers that there will always be a sustainable demand for the product. Hypertension is a condition which was recognized in the United States much ahead of many of the other regions with the antihypertensive drugs being sold right from day one in this country. There are also cases of a number of individuals taking these drugs as a preventive measure, as many doctors believe that the age group that this affects is slowly increasing in terms of range. Unless there are drastic lifestyle changes and changes in the diets of individuals, hypertension is expected to affect a vast volume of the working population over the next few years, especially in the APAC region with a number of companies and individuals working across different time zones.

Antihypertensive Drugs Market

The Antihypertensive Drugs market can be segmented on the basis of type as:

Diuretics

Angiotensin Converting Enzyme (ACE) Inhibitors

Angiotensin Receptor Blockers (ARBs)

Calcium Channel Blockers

Beta Blockers

Alpha Blockers

Vasodilators

Renin Inhibitors

The market has been segmented based on the following geographies:

North America

South America

APAC

Europe

Middle East

Africa

Following are just a few of the companies that are operating in the Antihypertensive Drugs market:

Astra Zeneca Plc

Daiichi Sankyo Company

Johnson & Johnson Ltd

Lupin Limited

Merck & Co

Table of Contents
for Antihypertensive Drugs Market Analysis: By Type (Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, ARBs, Calcium Channel Blockers, Beta Blockers, Alpha Blockers, Vasodilators & Renin Inhibitors); – With Forecast (2016-2021) [Report Updated: 27-01-2016]

  • 1. Antihypertensive Drugs– Market Overview

    2. Executive Summary

    3. Antihypertensive Drugs– Market Landscape

    3.1. Market Share Analysis

    3.2. Comparative Analysis

    3.2.1. Product Benchmarking

    3.2.2. End User Profiling

    3.2.3. Top 5 Financials Analysis

    4. Antihypertensive Drugs– Market Forces

    4.1. Market Drivers

    4.2. Market Constraints

    4.3. Market Challenges

    4.4. Attractiveness of the Antihypertensive Drugs Market

    4.4.1. Power of Suppliers

    4.4.2. Power of Customers

    4.4.3. Threat of New Entrants

    4.4.4. Threat of Substitution

    4.4.5. Degree of Competition

    5. Antihypertensive Drugs Market – Strategic Analysis

    5.1. Value Chain Analysis

    5.2. Pricing Analysis

    5.3. Opportunities Analysis

    5.4. Product/Market Life Cycle Analysis

    5.5. Suppliers and Distributors

    6. Antihypertensive Drugs Market– By Type

    6.1. Diuretics

    6.2. Angiotensin Converting Enzyme (ACE) Inhibitors

    6.3. Angiotensin Receptor Blockers (ARBs)

    6.4. Calcium Channel Blockers

    6.5. Beta Blockers

    6.6. Alpha Blockers

    6.7. Vasodilators

    6.8. Renin Inhibitors

    7. Antihypertensive Drugs Market– By Geography

    7.1. Introduction

    7.2. Global Study

    7.3. Americas

    7.3.1. North America

    7.3.2. Brazil

    7.3.3. Argentina

    7.3.4. Others

    7.4. Europe

    7.4.1. U.K.

    7.4.2. France

    7.4.3. Germany

    7.4.4. Others

    7.5. APAC

    7.5.1. China

    7.5.2. Japan

    7.5.3. India

    7.5.4. Others

    7.6. ROW

    8. Antihypertensive Drugs Market Entropy

    8.1. New Product Launches

    8.2. M&As, Collaborations, JVs and Partnerships

    9. Company Profiles

    9.1. Astra Zeneca Plc

    9.2. Daiichi Sankyo Company

    9.3. Johnson & Johnson Ltd

    9.4. Lupin Limited

    9.5. Merck & Co

    9.6. Novartis AG

    9.7. Pfizer

    9.8. Ranbaxy Laboratories Limited

    9.9. Sanofi S.A

    9.10. Takeda Pharmaceutical Company

    *More than 40 Companies are profiled in this Research Report, Complete List available on Request*

    "*Financials would be provided on a best efforts basis for private companies"

    10. Appendix

    10.1. Abbreviations

    10.2. Sources

    10.3. Research Methodology

    10.4. Bibliography

    10.5. Compilation of Expert Insights

    10.6. Disclaimer

List Of Tables
in Antihypertensive Drugs Market Analysis: By Type (Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, ARBs, Calcium Channel Blockers, Beta Blockers, Alpha Blockers, Vasodilators & Renin Inhibitors); – With Forecast (2016-2021) [Report Updated: 27-01-2016]

No

Additional Details

Publisher

Publisher Information

Reference

80065 | HCR 0143

Report Format

PDF

 Reports

We Stock...